214 related articles for article (PubMed ID: 33498084)
1. Tissue-specific control of galectin-1-driven circuits during inflammatory responses.
Cutine AM; Bach CA; Veigas F; Merlo JP; Laporte L; Manselle Cocco MN; Massaro M; Sarbia N; Perrotta RM; Mahmoud YD; Rabinovich GA
Glycobiology; 2021 Sep; 31(8):891-907. PubMed ID: 33498084
[TBL] [Abstract][Full Text] [Related]
2. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
[TBL] [Abstract][Full Text] [Related]
3. Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease Patients.
Sundblad V; Quintar AA; Morosi LG; Niveloni SI; Cabanne A; Smecuol E; Mauriño E; Mariño KV; Bai JC; Maldonado CA; Rabinovich GA
Front Immunol; 2018; 9():379. PubMed ID: 29545799
[TBL] [Abstract][Full Text] [Related]
4. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
5. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.
Bi S; Earl LA; Jacobs L; Baum LG
J Biol Chem; 2008 May; 283(18):12248-58. PubMed ID: 18258591
[TBL] [Abstract][Full Text] [Related]
6. Analysis of selected blood and immune cell responses to carbohydrate-dependent surface binding of proto- and chimera-type galectins.
Timoshenko AV; Gorudko IV; Maslakova OV; André S; Kuwabara I; Liu FT; Kaltner H; Gabius HJ
Mol Cell Biochem; 2003 Aug; 250(1-2):139-49. PubMed ID: 12962152
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.
Laderach DJ; Compagno D; Toscano MA; Croci DO; Dergan-Dylon S; Salatino M; Rabinovich GA
IUBMB Life; 2010 Jan; 62(1):1-13. PubMed ID: 20014236
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Molecular Interactions of Symmetrical and Unsymmetrical Selenoglycosides with Human Galectin-1 and Galectin-3.
Pirone L; Nieto-Fabregat F; Di Gaetano S; Capasso D; Russo R; Traboni S; Molinaro A; Iadonisi A; Saviano M; Marchetti R; Silipo A; Pedone E
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955408
[TBL] [Abstract][Full Text] [Related]
9. Untangling Galectin-Driven Regulatory Circuits in Autoimmune Inflammation.
Toscano MA; Martínez Allo VC; Cutine AM; Rabinovich GA; Mariño KV
Trends Mol Med; 2018 Apr; 24(4):348-363. PubMed ID: 29555188
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of endogenous Galectin-1 and -9 expression in monocyte and macrophage subsets under resting and inflammatory conditions.
Krautter F; Recio C; Hussain MT; Lezama DR; Maione F; Chimen M; Iqbal AJ
Biomed Pharmacother; 2020 Oct; 130():110595. PubMed ID: 32771893
[TBL] [Abstract][Full Text] [Related]
11. The universe of galectin-binding partners and their functions in health and disease.
Troncoso MF; Elola MT; Blidner AG; Sarrias L; Espelt MV; Rabinovich GA
J Biol Chem; 2023 Dec; 299(12):105400. PubMed ID: 37898403
[TBL] [Abstract][Full Text] [Related]
12. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors.
Etulain J; Negrotto S; Tribulatti MV; Croci DO; Carabelli J; Campetella O; Rabinovich GA; Schattner M
PLoS One; 2014; 9(4):e96402. PubMed ID: 24788652
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
Glycobiology; 2009 Feb; 19(2):112-7. PubMed ID: 18977853
[TBL] [Abstract][Full Text] [Related]
14. Galectin-1: A Traditionally Immunosuppressive Protein Displays Context-Dependent Capacities.
Yu X; Qian J; Ding L; Yin S; Zhou L; Zheng S
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047471
[TBL] [Abstract][Full Text] [Related]
15. Role of Galectins in Tumors and in Clinical Immunotherapy.
Chou FC; Chen HY; Kuo CC; Sytwu HK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
[TBL] [Abstract][Full Text] [Related]
16. Human galectin-1 and galectin-3 promote
Ayona D; Zarza SM; Landemarre L; Roubinet B; Decloquement P; Raoult D; Fournier PE; Desnues B
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33573443
[No Abstract] [Full Text] [Related]
17. Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?
Toscano MA; Ilarregui JM; Bianco GA; Campagna L; Croci DO; Salatino M; Rabinovich GA
Cytokine Growth Factor Rev; 2007; 18(1-2):57-71. PubMed ID: 17321195
[TBL] [Abstract][Full Text] [Related]
18. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
19. Glycan Chains of Gangliosides: Functional Ligands for Tissue Lectins (Siglecs/Galectins).
Ledeen RW; Kopitz J; Abad-Rodríguez J; Gabius HJ
Prog Mol Biol Transl Sci; 2018; 156():289-324. PubMed ID: 29747818
[TBL] [Abstract][Full Text] [Related]
20. Chemokines modulate glycan binding and the immunoregulatory activity of galectins.
Sanjurjo L; Schulkens IA; Touarin P; Heusschen R; Aanhane E; Castricum KCM; De Gruijl TD; Nilsson UJ; Leffler H; Griffioen AW; Elantak L; Koenen RR; Thijssen VLJL
Commun Biol; 2021 Dec; 4(1):1415. PubMed ID: 34931005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
